Achieve Life Sciences Inc
Ownership
Ownership Structure
Who owns Achieve Life Sciences Inc (ACHV)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 72.4% of the shares are freely tradable; institutional investors hold 61.0%.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 7.39 | 7,614,836 | +0.0 | 06/30/2026 |
| TPG GP A, LLC | 6.67 | 6,877,580 | +0.0 | 06/30/2026 |
| venBio Partners LLC | 5.74 | 5,914,720 | +0.0 | 06/30/2026 |
| Logos Global Management LP | 5.26 | 5,425,000 | +0.0 | 06/30/2026 |
| BlackRock Inc | 5.11 | 5,272,017 | +1,099.9 | 06/30/2026 |
| Franklin Templeton Inc | 4.80 | 4,953,220 | +13.4 | 06/30/2026 |
| Paradigm Biocapital Advisors LP | 4.80 | 4,951,856 | +0.0 | 06/30/2026 |
| Vanguard Capital Management, LLC | 4.02 | 4,140,812 | +87.8 | 06/30/2026 |
| Propel Bio Management LLC | 3.91 | 4,034,018 | +6.5 | 06/30/2026 |
| Marshall Wace Asset Management Ltd | 3.66 | 3,770,313 | +269.9 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Insider holdings
| Person | Role | Shares | Value | As of | Type |
|---|---|---|---|---|---|
| Stewart Richard Alistair | Director | 208,249 | 1,374,443 $ | Aug 19, 2026 | direct |
Holdings as of each person's most recent SEC Form 4 filing — excluding options and RSUs, which are not shares yet. Holdings may have changed between two filings.
Insiders
Insider Transactions
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Aug 19, 2026 | Stewart Richard Alistair | Director | Sell | 20,626 | 8.49 | 175,177 |
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character. View all insider transactions →
Data as of: November 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.